222 related articles for article (PubMed ID: 8095852)
21. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.
Korkolopoulou P; Oates J; Crocker J; Edwards C
J Clin Pathol; 1993 Dec; 46(12):1093-6. PubMed ID: 7904273
[TBL] [Abstract][Full Text] [Related]
22. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.
Klemi PJ; Alanen K; Jalkanen S; Joensuu H
Br J Cancer; 1992 Oct; 66(4):739-43. PubMed ID: 1358164
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance of proliferating cell nuclear antigen in patients with lymph node-positive breast cancer.
Sheen-Chen SM; Eng HL; Chou FF; Chen WJ
Arch Surg; 1997 Mar; 132(3):264-7. PubMed ID: 9125025
[TBL] [Abstract][Full Text] [Related]
24. Reduced survival of rectal cancer patients with increased tumor epidermal growth factor receptor levels.
Kopp R; Rothbauer E; Mueller E; Schildberg FW; Jauch KW; Pfeiffer A
Dis Colon Rectum; 2003 Oct; 46(10):1391-9. PubMed ID: 14530681
[TBL] [Abstract][Full Text] [Related]
25. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
26. The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma.
Oda Y; Hashimoto H; Takeshita S; Tsuneyoshi M
Cancer; 1993 Jul; 72(2):478-85. PubMed ID: 8100481
[TBL] [Abstract][Full Text] [Related]
27. Relationships among the expression of epidermal growth factor receptor, proliferating cell nuclear antigen labeling index, and lymph node metastasis in gastric cancer.
Iida A; Hirose K; Arai M; Yamaguchi A; Nakagawara G
Oncology; 1995; 52(3):189-95. PubMed ID: 7715902
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of proliferating cell nuclear antigen in lymph node-negative breast cancer patients.
Bianchi S; Paglierani M; Zampi G; Cardona G; Cataliotti L; Bonardi R; Zappa M; Ciatto S
Cancer; 1993 Jul; 72(1):120-5. PubMed ID: 8099532
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases.
Fukuse T; Hirata T; Naiki H; Hitomi S; Wada H
Ann Surg; 2000 Jul; 232(1):112-8. PubMed ID: 10862203
[TBL] [Abstract][Full Text] [Related]
30. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
[TBL] [Abstract][Full Text] [Related]
31. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.
Jain S; Filipe MI; Hall PA; Waseem N; Lane DP; Levison DA
J Clin Pathol; 1991 Aug; 44(8):655-9. PubMed ID: 1679766
[TBL] [Abstract][Full Text] [Related]
33. Proliferative activity of gastric cancer assessed by immunostaining for proliferating cell nuclear antigen.
Inada T; Imura J; Ichikawa A; Ogata Y; Shimamura K
J Surg Oncol; 1993 Nov; 54(3):146-51; discussion 151-2. PubMed ID: 8105151
[TBL] [Abstract][Full Text] [Related]
34. Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy.
Yonemura Y; Kimura H; Fushida S; Tugawa K; Nakai Y; Kaji M; Fonseca L; Yamaguchi A; Miyazaki I
Cancer; 1993 Apr; 71(8):2448-53. PubMed ID: 8095851
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in non-small cell lung cancer.
Fujii M; Motoi M; Saeki H; Aoe K; Moriwaki S
Acta Med Okayama; 1993 Apr; 47(2):103-8. PubMed ID: 8099466
[TBL] [Abstract][Full Text] [Related]
36. [The expression of proliferating cell nuclear antigen (PCNA) immunostaining in renal pelvic and ureteral cancers and its prognostic value].
Kamijo T; Sato T; Yanagizawa R; Kishi H
Nihon Hinyokika Gakkai Zasshi; 1994 Jun; 85(6):938-44. PubMed ID: 7914944
[TBL] [Abstract][Full Text] [Related]
37. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
38. Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.
Thomas M; Noguchi M; Kitagawa H; Kinoshita K; Miyazaki I
J Clin Pathol; 1993 Jun; 46(6):525-8. PubMed ID: 8101192
[TBL] [Abstract][Full Text] [Related]
39. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
[TBL] [Abstract][Full Text] [Related]
40. Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes' stage C or D.
Zhang JC; Wang ZR; Cheng YJ; Yang DZ; Shi JS; Liang AL; Liu NN; Wang XM
World J Gastroenterol; 2003 Jul; 9(7):1482-6. PubMed ID: 12854146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
